Weekly scans may make proton therapy safer for kids with cancer
NCT ID NCT07514819
First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study will enroll 100 children with solid tumors or Hodgkin lymphoma who are receiving proton therapy. Researchers will take weekly or bi-weekly CT or MRI scans during treatment to check if the original radiation plan is still accurate. If tumor coverage drops by 5% or radiation to healthy organs rises by 10%, the plan will be updated. The goal is to see how often adjustments are needed and which tumors change most during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Proton therapy with adaptive replanning
- What this could lead to
- If successful, this approach could make proton therapy more precise for children, potentially reducing damage to healthy tissues and improving tumor control.
- What could go wrong
- This is an early-stage observational study with no control group, so it cannot prove that adaptive planning improves outcomes. The findings may not apply to all tumor types or treatment centers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can a radioactive antibody light up hidden tumors?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can engineered immune cells tackle childhood sarcoma?
- Can AI read tumor slides to outsmart childhood cancer?